InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Weill David. Director active across 1 company, notably TransMedics Group, Inc.. Aggregated, 9 reports have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €600k. History available since 10 November 2022. The latest transaction was filed on 3 December 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Weill David is a declarant and a director of TransMedics Group, Inc. (XNAS). He has 8 filings in total, and across the 8 recent filings available, the reported buys amount to EUR 142605 and the reported sells to EUR 457367, between 2022-11-14 and 2025-05-23, with Attribution as the modal transaction nature.